Hospira recalls another product made at Australian plant cited by FDA

Hospira ($HSP) is recalling another product manufactured at a plant in Australia, which last year received an FDA warning letter. The Lake Forest, IL-based company is voluntarily recalling 3,306 vials of the cancer drug dacarbazine because of discoloration, according to the most recent FDA Enforcement Report. It said the reconstituted solution may appear pink instead of colorless to pale yellow when stored according to labeled conditions. The drug came from its plant in Mulgrave, Victoria, which was issued a warning letter by the FDA in September for its tardiness in investigating out-of-specification test results in some products. One of those products was the cancer med mitoxantrone. Last month, the company began recalling 10 lots of that drug. Report | More